EJNMMI Radiopharmacy and Chemistry View Homepage


Ontology type: schema:Periodical      Open Access: True


Journal Info

START YEAR

2016

PUBLISHER

Springer International Publishing

LANGUAGE

en

HOMEPAGE

http://ejnmmipharmchem.springeropen.com

Recent publications latest 20 shown

  • 2019-12 Radiosynthesis and in vivo evaluation of 11C-labeled BMS-193885 and its desmethyl analog as PET tracers for neuropeptide Y1 receptors
  • 2019-12 Synthesis of a benzoxazinthione derivative of tanaproget and pharmacological evaluation for PET imaging of PR expression
  • 2019-12 Radiochemical and analytical aspects of inter-institutional quality control measurements on radiopharmaceuticals
  • 2019-12 Automated synthesis of [11C]L-glutamine on Synthra HCN plus synthesis module
  • 2019-12 The new Regulation on clinical trials in relation to radiopharmaceuticals: when and how will it be implemented?
  • 2019-12 Molecular imaging of multiple sclerosis: from the clinical demand to novel radiotracers
  • 2018-12 Comparison of fully-automated radiosyntheses of [11C]erlotinib for preclinical and clinical use starting from in target produced [11C]CO2 or [11C]CH4
  • 2018-12 Synthesis of an Al18F radiofluorinated GLU-UREA-LYS(AHX)-HBED-CC PSMA ligand in an automated synthesis platform
  • 2018-12 Production of novel diagnostic radionuclides in small medical cyclotrons
  • 2018-12 Radiosynthesis and evaluation of an 18F–labeled silicon containing exendin-4 peptide as a PET probe for imaging insulinoma
  • 2018-12 An alternative methodology for the determination of the radiochemical purity of 11C-methionine
  • 2018-12 Synthesis, radiosynthesis, in vitro and first in vivo evaluation of a new matrix metalloproteinase inhibitor based on γ-fluorinated α-sulfonylaminohydroxamic acid
  • 2018-12 A random walk approach to estimate the confinement of α-particle emitters in nanoparticles for targeted radionuclide therapy
  • 2018-12 Publisher Correction to EJNMMI Radiopharmacy and Chemistry Volume 1 (2016)
  • 2018-12 Synthesis and preliminary preclinical evaluation of fluorine-18 labelled isatin-4-(4-methoxyphenyl)-3-thiosemicarbazone ([18F]4FIMPTC) as a novel PET tracer of P-glycoprotein expression
  • 2018-12 Preparation and preclinical evaluation of a 68Ga-labelled c(RGDfK) conjugate comprising the bifunctional chelator NODIA-Me
  • 2018-12 A new two-strip TLC method for the quality control of technetium-99m mercaptoacetyl-triglycine (99mTc-MAG3)
  • 2018-12 A high molar activity 18F-labeled TAK-875 derivative for PET imaging of pancreatic β-cells
  • 2018-12 Futureproofing [18F]Fludeoxyglucose manufacture at an Academic Medical Center
  • 2018-12 Metabolite profiling with HPLC-ICP-MS as a tool for in vivo characterization of imaging probes
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://scigraph.springernature.com/ontologies/product-market-codes/H29048", 
            "inDefinedTermSet": "http://scigraph.springernature.com/ontologies/product-market-codes/", 
            "name": "Nuclear Medicine", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://scigraph.springernature.com/ontologies/product-market-codes/H29005", 
            "inDefinedTermSet": "http://scigraph.springernature.com/ontologies/product-market-codes/", 
            "name": "Imaging / Radiology", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://scigraph.springernature.com/ontologies/product-market-codes/C31000", 
            "inDefinedTermSet": "http://scigraph.springernature.com/ontologies/product-market-codes/", 
            "name": "Nuclear Chemistry", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://scigraph.springernature.com/ontologies/product-market-codes/H69000", 
            "inDefinedTermSet": "http://scigraph.springernature.com/ontologies/product-market-codes/", 
            "name": "Pharmacotherapy", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://scigraph.springernature.com/ontologies/product-market-codes/B1700X", 
            "inDefinedTermSet": "http://scigraph.springernature.com/ontologies/product-market-codes/", 
            "name": "Molecular Medicine", 
            "type": "DefinedTerm"
          }
        ], 
        "description": "

    EJNMMI Radiopharmacy and Chemistry is a peer-reviewed\u00a0open access Journal and publishes new research in the field of development of new imaging and radionuclide-based therapeutic agents for application in nuclear medicine and molecular imaging. The journal provides a platform for chemists, pharmacists and basic scientists to present their views and scientific work. In addition, the journal provides insight into novel concepts of imaging or radionuclide-based therapeutic agent applications of relevance for the whole molecular imaging community. The journal reports original research articles, review papers, guidelines on the application of imaging or radionuclide therapy agents, editorials, and letters to the editor. Research articles on novel radiochemistry, new radiopharmaceuticals including their first biological evaluation, molecular imaging agents including optical imaging, MRI, and hybrid probes, are the main focus of the journal. To translate imaging and radionuclide therapy agents to the clinic, legislative issues related to their production and safety can be presented as well in the form of guidelines or position papers.

    Peer review is conducted using Editorial Manager\u00ae, supported by a database of international experts. This database is shared with the journals European Journal of Nuclear Medicine and Molecular Imaging, EJNMMI Physics, EJNMMI Research, and the European Journal of Hybrid Imaging.

    ", "editor": [ { "familyName": "Elsinga", "givenName": "Philip H.", "type": "Person" } ], "id": "sg:journal.1157056", "inLanguage": [ "en" ], "isAccessibleForFree": true, "issn": [ "2365-421X" ], "license": "Fully Open Access", "name": "EJNMMI Radiopharmacy and Chemistry", "productId": [ { "name": "nsd_ids_id", "type": "PropertyValue", "value": [ "493509" ] }, { "name": "springer_id", "type": "PropertyValue", "value": [ "41181" ] }, { "name": "lccn_id", "type": "PropertyValue", "value": [ "2016247781" ] }, { "name": "dimensions_id", "type": "PropertyValue", "value": [ "157056" ] }, { "name": "nlm_unique_id", "type": "PropertyValue", "value": [ "101714628" ] } ], "publisher": { "name": "Springer International Publishing", "type": "Organization" }, "publisherImprint": "Springer", "sameAs": [ "https://app.dimensions.ai/discover/publication?and_facet_source_title=jour.1157056" ], "sdDataset": "journals", "sdDatePublished": "2019-03-18T11:05", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "file:///home/ubuntu/piotr/scigraph_export/journals_20190313_sn_only.jsonl", "startYear": "2016", "type": "Periodical", "url": "http://ejnmmipharmchem.springeropen.com" } ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/journal.1157056'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/journal.1157056'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/journal.1157056'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/journal.1157056'


     

    This table displays all metadata directly associated to this object as RDF triples.

    67 TRIPLES      20 PREDICATES      29 URIs      20 LITERALS      8 BLANK NODES

    Subject Predicate Object
    1 sg:journal.1157056 schema:about sg:ontologies/product-market-codes/B1700X
    2 sg:ontologies/product-market-codes/C31000
    3 sg:ontologies/product-market-codes/H29005
    4 sg:ontologies/product-market-codes/H29048
    5 sg:ontologies/product-market-codes/H69000
    6 schema:description <p><i>EJNMMI Radiopharmacy and Chemistry </i>is a peer-reviewed open access Journal and publishes new research in the field of development of new imaging and radionuclide-based therapeutic agents for application in nuclear medicine and molecular imaging. The journal provides a platform for chemists, pharmacists and basic scientists to present their views and scientific work. In addition, the journal provides insight into novel concepts of imaging or radionuclide-based therapeutic agent applications of relevance for the whole molecular imaging community. The journal reports original research articles, review papers, guidelines on the application of imaging or radionuclide therapy agents, editorials, and letters to the editor. Research articles on novel radiochemistry, new radiopharmaceuticals including their first biological evaluation, molecular imaging agents including optical imaging, MRI, and hybrid probes, are the main focus of the journal. To translate imaging and radionuclide therapy agents to the clinic, legislative issues related to their production and safety can be presented as well in the form of guidelines or position papers.</p><p>Peer review is conducted using Editorial Manager®, supported by a database of international experts. This database is shared with the journals <i>European Journal of Nuclear Medicine and Molecular Imaging, EJNMMI Physics,</i> <i>EJNMMI Research, </i>and the<i> European Journal of Hybrid Imaging.</i></p>
    7 schema:editor N8a3341e8ea664d28862735a8ca65a0d9
    8 schema:inLanguage en
    9 schema:isAccessibleForFree true
    10 schema:issn 2365-421X
    11 schema:license Fully Open Access
    12 schema:name EJNMMI Radiopharmacy and Chemistry
    13 schema:productId N10f0f5a506804dbe84ed146ae892abb9
    14 N7363a0d702da4561b448ae0bfdacf77a
    15 Nc2eb006a749142788c89f4f0ff331a68
    16 Nea635b43ec2d464bac848caf4ba01084
    17 Nf91fa51bdee446189fbcc9bd081f9079
    18 schema:publisher Nedbff18c0b9644c69863cd5d7765c5bc
    19 schema:publisherImprint Springer
    20 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_source_title=jour.1157056
    21 schema:sdDatePublished 2019-03-18T11:05
    22 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    23 schema:sdPublisher N00109fe6c4b0446e91910030fcd1903a
    24 schema:startYear 2016
    25 schema:url http://ejnmmipharmchem.springeropen.com
    26 sgo:license sg:explorer/license/
    27 sgo:sdDataset journals
    28 rdf:type schema:Periodical
    29 N00109fe6c4b0446e91910030fcd1903a schema:name Springer Nature - SN SciGraph project
    30 rdf:type schema:Organization
    31 N10f0f5a506804dbe84ed146ae892abb9 schema:name nsd_ids_id
    32 schema:value 493509
    33 rdf:type schema:PropertyValue
    34 N7363a0d702da4561b448ae0bfdacf77a schema:name lccn_id
    35 schema:value 2016247781
    36 rdf:type schema:PropertyValue
    37 N8a3341e8ea664d28862735a8ca65a0d9 rdf:first Nb7131772726e4498a6fddff4f0157f6e
    38 rdf:rest rdf:nil
    39 Nb7131772726e4498a6fddff4f0157f6e schema:familyName Elsinga
    40 schema:givenName Philip H.
    41 rdf:type schema:Person
    42 Nc2eb006a749142788c89f4f0ff331a68 schema:name nlm_unique_id
    43 schema:value 101714628
    44 rdf:type schema:PropertyValue
    45 Nea635b43ec2d464bac848caf4ba01084 schema:name dimensions_id
    46 schema:value 157056
    47 rdf:type schema:PropertyValue
    48 Nedbff18c0b9644c69863cd5d7765c5bc schema:name Springer International Publishing
    49 rdf:type schema:Organization
    50 Nf91fa51bdee446189fbcc9bd081f9079 schema:name springer_id
    51 schema:value 41181
    52 rdf:type schema:PropertyValue
    53 sg:ontologies/product-market-codes/B1700X schema:inDefinedTermSet sg:ontologies/product-market-codes/
    54 schema:name Molecular Medicine
    55 rdf:type schema:DefinedTerm
    56 sg:ontologies/product-market-codes/C31000 schema:inDefinedTermSet sg:ontologies/product-market-codes/
    57 schema:name Nuclear Chemistry
    58 rdf:type schema:DefinedTerm
    59 sg:ontologies/product-market-codes/H29005 schema:inDefinedTermSet sg:ontologies/product-market-codes/
    60 schema:name Imaging / Radiology
    61 rdf:type schema:DefinedTerm
    62 sg:ontologies/product-market-codes/H29048 schema:inDefinedTermSet sg:ontologies/product-market-codes/
    63 schema:name Nuclear Medicine
    64 rdf:type schema:DefinedTerm
    65 sg:ontologies/product-market-codes/H69000 schema:inDefinedTermSet sg:ontologies/product-market-codes/
    66 schema:name Pharmacotherapy
    67 rdf:type schema:DefinedTerm
     




    Preview window. Press ESC to close (or click here)


    ...